Latest Australian Markets News

RLF AgTech Ltd has closed FY2025 with a remarkable 74% increase in customer receipts and positive operating cash flow, underpinned by a comprehensive restructuring and renewed market momentum across Australia, China, and Asia.

QuickFee Limited reports a record A$7.2 million quarterly revenue, driven by strong US and Australian growth, alongside positive underlying profitability and a major refinancing.

Genetic Signatures reported steady quarterly sales of $4.4 million, reflecting seasonal demand in Australia, while restructuring its US operations to accelerate growth. A new US contract and strategic partnerships signal potential for future expansion.

RBR Group stands uniquely positioned as the only ASX-listed company directly linked to Mozambique’s LNG megaprojects, gearing up for a sector revival and broader African growth.

BKI Investment Company Limited reported a modest rise in revenue and operating profit for FY2025, alongside a 1% increase in dividends, supported by robust returns from key portfolio holdings.

Centrepoint Alliance has reported a robust FY25 with EBITDA rising 16% and net profit before tax jumping 30%, driven by strong adviser growth and strategic platform launches.

Little Green Pharma reported a robust June 2025 quarter with record cash receipts and expanding European footprint, highlighted by a new production capacity in Denmark and the launch of its CherryCo brand in Germany.

betr Entertainment Limited has launched an all-scrip takeover bid for PointsBet Holdings Limited, offering 3.81 betr shares for every PointsBet share, valuing PointsBet at $1.22 per share and promising significant cost synergies.

Kinterra Capital has lodged a formal review application against the Takeovers Panel’s earlier ruling involving New World Resources, signaling potential shifts in the ongoing corporate governance saga.

Lendlease has expanded its Australian development pipeline with a landmark $2.5 billion luxury residential project at 175 Liverpool Street, Sydney, signaling strong confidence in the high-end market and its strategic growth plans.

Finbar Group has signed a conditional contract to sell a key Rivervale site for $13.68 million, paving the way for a large-scale build-to-rent development backed by community housing initiatives.

Orthocell Limited has posted a record quarterly revenue of A$2.73 million, driven by strong Australian sales of its nerve repair product Remplir™, with US market expansion poised to accelerate in FY26.